Introduction {#Sec1}
============

High-throughput nucleic acid sequencing \[[@CR1]\] and mass-spectrometry proteomics \[[@CR2]\] have provided us with a deluge of data for DNA, RNA, and proteins in diverse species. However, extracting detailed functional information from such data remains one of the recalcitrant challenges in the life sciences and biomedicine. Low-throughput biological experiments often provide highly informative empirical data related to various functional aspects of a gene product, but these experiments are limited by time and cost. At the same time, high-throughput experiments, while providing large amounts of data, often provide information that is not specific enough to be useful \[[@CR3]\]. For these reasons, it is important to explore computational strategies for transferring functional information from the group of functionally characterized macromolecules to others that have not been studied for particular activities \[[@CR4]--[@CR9]\].

To address the growing gap between high-throughput data and deep biological insight, a variety of computational methods that predict protein function have been developed over the years \[[@CR10]--[@CR24]\]. This explosion in the number of methods is accompanied by the need to understand how well they perform, and what improvements are needed to satisfy the needs of the life sciences community. The Critical Assessment of Functional Annotation (CAFA) is a community challenge that seeks to bridge the gap between the ever-expanding pool of molecular data and the limited resources available to understand protein function \[[@CR25]--[@CR27]\].

The first two CAFA challenges were carried out in 2010--2011 \[[@CR25]\] and 2013--2014 \[[@CR26]\]. In CAFA1, we adopted a time-delayed evaluation method, where protein sequences that lacked experimentally verified annotations, or *targets*, were released for prediction. After the submission deadline for predictions, a subset of these targets accumulated experimental annotations over time, either as a consequence of new publications about these proteins or the biocuration work updating the annotation databases. The members of this set of proteins were used as *benchmarks* for evaluating the participating computational methods, as the function was revealed only after the prediction deadline.

CAFA2 expanded the challenge founded in CAFA1. The expansion included the number of ontologies used for predictions, the number of target and benchmark proteins, and the introduction of new assessment metrics that mitigate the problems with functional similarity calculation over concept hierarchies such as Gene Ontology \[[@CR28]\]. Importantly, we provided evidence that the top-scoring methods in CAFA2 outperformed the top-scoring methods in CAFA1, highlighting that methods participating in CAFA improved over the 3-year period. Much of this improvement came as a consequence of novel methodologies with some effect of the expanded annotation databases \[[@CR26]\]. Both CAFA1 and CAFA2 have shown that computational methods designed to perform function prediction outperform a conventional function transfer through sequence similarity \[[@CR25], [@CR26]\].

In CAFA3 (2016--2017), we continued with all types of evaluations from the first 2 challenges and additionally performed experimental screens to identify genes associated with specific functions. This allowed us to provide unbiased evaluation of the term-centric performance based on a unique set of benchmarks obtained by assaying *Candida albicans*, *Pseudomonas aeruginosa*, and *Drosophila melanogaster*. We also held a challenge following CAFA3, dubbed CAFA- *π*, to provide the participating teams another opportunity to develop or modify prediction models. The genome-wide screens on *C. albicans* identified 240 genes previously not known to be involved in biofilm formation, whereas the screens on *P. aeruginosa* identified 532 new genes involved in biofilm formation and 403 genes involved in motility. Finally, we used CAFA predictions to select genes from *D. melanogaster* and assay them for long-term memory involvement. This experiment allowed us to both evaluate prediction methods and identify 11 new fly genes involved in this biological process \[[@CR29]\]. Here, we present the outcomes of the CAFA3 challenge, as well as the accompanying challenge CAFA- *π*, and discuss further directions for the community interested in the function of biological macromolecules.

Results {#Sec2}
=======

Top methods have improved from CAFA2 to CAFA3, but improvement was less dramatic than from CAFA1 to CAFA2 {#Sec3}
---------------------------------------------------------------------------------------------------------

One of CAFA's major goals is to quantify the progress in function prediction over time. We therefore conducted a comparative evaluation of top CAFA1, CAFA2, and CAFA3 methods according to their ability to predict Gene Ontology \[[@CR28]\] terms on a set of common benchmark proteins. This benchmark set was created as an intersection of CAFA3 benchmarks (proteins that gained experimental annotation after the CAFA3 prediction submission deadline) and CAFA1 and CAFA2 target proteins. Overall, this set contained 377 protein sequences with annotations in the Molecular Function Ontology (MFO), 717 sequences in the Biological Process Ontology (BPO), and 548 sequences in the Cellular Component Ontology (CCO), which allowed for a direct comparison of all methods that have participated in the challenges so far. The head-to-head comparisons in MFO, BPO, and CCO between the top 5 CAFA3 and CAFA2 methods are shown in Fig. [1](#Fig1){ref-type="fig"}. CAFA3 and CAFA1 comparisons are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1. Fig. 1A comparison in *F*~max~ between the top 5 CAFA2 models against the top 5 CAFA3 models. Colored boxes encode the results such that (1) the colors indicate margins of a CAFA3 method over a CAFA2 method in *F*~max~ and (2) the numbers in the box indicate the percentage of wins. **a** CAFA2 top 5 models (rows, from top to bottom) against CAFA3 top 5 models (columns, from left to right). **b** Comparison of the performance (*F*~max~) of Naïve baselines trained respectively on SwissProt2014 and SwissProt2017. Colored box between the two bars shows the percentage of wins and margin of wins as in **a**. **c** Comparison of the performance (*F*~max~) of BLAST baselines trained on SwissProt2014 and SwissProt2017. Colored box between the two bars shows the percentage of wins and margin of wins as in **a**. Statistical significance was assessed using 10,000 bootstrap samples of benchmark proteins

We first observe that, in effect, the performance of baseline methods \[[@CR25], [@CR26]\] has not improved since CAFA2. The Naïve method, which uses the term frequency in the existing annotation database as a prediction score for every input protein, has the same *F*~max~ performance using both annotation databases in 2014 (when CAFA2 was held) and in 2017 (when CAFA3 was held), which suggests little change in term frequencies in the annotation database since 2014. In MFO, the BLAST method based on the existing annotations in 2017 is slightly but significantly better than the BLAST method based on 2014 training data. In BPO and CCO, however, the BLAST based on the later database has not outperformed its earlier counterpart, although the changes in effect size (absolute change in *F*~max~) in both ontologies are small.

When surveying all 3 CAFA challenges, the performance of both baseline methods has been relatively stable, with some fluctuations of BLAST. Such performance of direct sequence-based function transfer is surprising, given the steady growth of annotations in UniProt-GOA \[[@CR30]\]; that is, there were 259,785 experimental annotations in 2011, 341,938 in 2014, and 434,973 in 2017, but there does not seem to be a definitive trend with the BLAST method, as they go up and down in *F*~max~ across ontologies. We conclude from these observations on the baseline methods that first, the ontologies are in different annotation states and should not be treated as a whole. In fact, the distribution of annotation depth and information content is very different across 3 ontologies, as shown in Additional file [1](#MOESM1){ref-type="media"}: Figures S15 and S16. Second, methods that perform direct function transfer based on sequence similarity do not necessarily benefit from a larger training dataset. Although the performance observed in our work is also dependent on the benchmark set, it appears that the annotation databases remain too sparsely populated to effectively exploit function transfer by sequence similarity, thus justifying the need for advanced methodology development for this problem.

Head-to-head comparisons of the top 5 CAFA3 methods against the top 5 CAFA2 methods show mixed results. In MFO, the top CAFA3 method, GOLabeler \[[@CR23]\], outperformed all CAFA2 methods by a considerable margin, as shown in Fig. [2](#Fig2){ref-type="fig"}. The rest of the 4 CAFA3 top methods did not perform as well as the top 2 methods of CAFA2, although only to a limited extent, with little change in *F*~max~. Of the top 12 methods ranked in MFO, 7 are from CAFA3, 5 are from CAFA2, and none from CAFA1. Despite the increase in database size, the majority of function prediction methods do not seem to have improved in predicting protein function in MFO since 2014, except for 1 method that stood out. In BPO, the top 3 methods in CAFA3 outperformed their CAFA2 counterparts, but with very small margins. Out of the top 12 methods in BPO, 8 are from CAFA3, 4 are from CAFA2, and none from CAFA1. Finally, in CCO, although 8 out of the top 12 methods over all CAFA challenges come from CAFA3, the top method is from CAFA2. The differences between the top-performing methods are small, as in the case of BPO. Fig. 2Performance evaluation based on the *F*~max~ for the top CAFA1, CAFA2, and CAFA3 methods. The top 12 methods are shown in this barplot ranked in descending order from left to right. The baseline methods are appended to the right; they were trained on training data from 2017, 2014, and 2011, respectively. Coverage of the methods were shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark that are predicted by the methods. Color scheme: CAFA2, ivory; CAFA3, green; Naïve, red; BLAST, blue. Note that in MFO and BPO, CAFA1 methods were ranked, but since none made to the top 12 of all 3 CAFA challenges, they were not displayed. The CAFA1 challenge did not collect predictions for CCO. **a**: molecular function; **b**: Biological process; **c**: Cellular Component

The performance of the top methods in CAFA2 was significantly better than of those in CAFA1, and it is interesting to note that this trend has not continued in CAFA3. This could be due to many reasons, such as the quality of the benchmark sets, the overall quality of the annotation database, the quality of ontologies, or a relatively short period of time between challenges.

Protein-centric evaluation {#Sec4}
--------------------------

The *protein-centric* evaluation measures the accuracy of assigning GO terms to a protein. This performance is shown in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. Fig. 3Performance evaluation based on the *F*~max~ for the top-performing methods in 3 ontologies. Evaluation was carried out on *No knowledge* benchmarks in the *full* mode. **a**--**c**: bar plots showing the *F*~max~ of the top 10 methods. The 95% confidence interval was estimated using 10,000 bootstrap iterations on the benchmark set. Coverage of the methods was shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark which are predicted by the methods. **d**--**f**: precision-recall curves for the top 10 methods. The perfect prediction should have *F*~max~=1, at the top right corner of the plot. The dot on the curve indicates where the maximum *F* score is achievedFig. 4Performance evaluation based on *S*~min~ for the top-performing methods in 3 ontologies. Evaluation was carried out on *No knowledge* benchmarks in the *full* mode. **a**--**c**: bar plots showing *S*~min~ of the top 10 methods. The 95% confidence interval was estimated using 10,000 bootstrap iterations on the benchmark set. Coverage of the methods was shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark which are predicted by the methods. **d**--**f**: remaining uncertainty-missing information (RU-MI) curves for the top 10 methods. The perfect prediction should have *S*~min~=0, at the bottom left corner of the plot. The dot on the curve indicates where the minimum semantic distance is achieved

We observe that all top methods outperform the baselines with the patterns of performance consistent with CAFA1 and CAFA2 findings. Predictions of MFO terms achieved the highest *F*~max~ compared with predictions in the other two ontologies. BLAST outperforms Naïve in predictions in MFO, but not in BPO or CCO. This is because sequence similarity-based methods such as BLAST tend to perform best when transferring basic biochemical annotations such as enzymatic activity. Functions in biological process, such as pathways, may not be as preserved by sequence similarity, hence the poor BLAST performance in BPO. The reasons behind the difference among the three ontologies include the structure and complexity of the ontology as well as the state of the annotation database, as discussed previously \[[@CR26], [@CR31]\]. It is less clear why the performance in CCO is weak, although it might be hypothesized that such performance is related to the structure of the ontology itself \[[@CR31]\].

The top-performing method in MFO did not have as high an advantage over others when evaluated using the *S*~min~ metric. The *S*~min~ metric weights GO terms by conditional information content, since the prediction of more informative terms is more desirable than less informative, more general, terms. This could potentially explain the smaller gap between the top predictor and the rest of the pack in *S*~min~. The weighted *F*~max~ and normalized *S*~min~ evaluations can be found in Additional file [1](#MOESM1){ref-type="media"}: Figures S4 and S5.

Species-specific categories {#Sec5}
---------------------------

The benchmarks in each species were evaluated individually as long as there were at least 15 proteins per species. Here, we present the results from eukaryotic and bacterial species (Fig. [5](#Fig5){ref-type="fig"}). We observed that different methods could perform differently on different species. As shown in Fig. [6](#Fig6){ref-type="fig"}, bacterial proteins make up a small portion of all benchmark sequences, so their effects on the performances of the methods are often masked. Species-specific analyses are therefore useful to researchers studying certain organisms. Evaluation results on individual species including human (Additional file [1](#MOESM1){ref-type="media"}: Figure S6), *Arabidopsis thaliana* (Additional file [1](#MOESM1){ref-type="media"}: Figure S7) and *Escherichia coli* (Additional file [1](#MOESM1){ref-type="media"}: Figure S10) can be found in Additional file [1](#MOESM1){ref-type="media"}: Figure S6-S14. Fig. 5Evaluation based on the *F*~max~ for the top-performing methods in eukaryotic and bacterial speciesFig. 6Number of proteins in each benchmark species and ontology

Diversity of methods {#Sec6}
--------------------

It was suggested in the analysis of CAFA2 that ensemble methods that integrate data from different sources have the potential of improving prediction accuracy \[[@CR32]\]. Multiple data sources, including sequence, structure, expression profile, genomic context, and molecular interaction data, are all potentially predictive of the function of the protein. Therefore, methods that take advantage of these rich sources as well as existing techniques from other research groups might see improved performance. Indeed, the one method that stood out from the rest in CAFA3 and performed significantly better than all methods across three challenges is a machine learning-based ensemble method \[[@CR23]\]. Therefore, it is important to analyze what information sources and prediction algorithms are better at predicting function. Moreover, the similarity of the methods might explain the limited improvement in the rest of the methods in CAFA3.

The top CAFA2 and CAFA3 methods are very similar in performance, but that could be a result of aggregating predictions of different proteins to one metric. When computing the similarity of each pair of methods as the Euclidean distance of prediction scores (Fig. [7](#Fig7){ref-type="fig"}), we are not interested whether these predictions are correct according to the benchmarks, but simply whether they are similar to one another. The diagonal blocks in Fig. [7](#Fig7){ref-type="fig"} show that CAFA1 top methods are more diverse than CAFA2 and CAFA3. The off-diagonal blocks shows that CAFA2 and CAFA3 methods are more similar with each other than with CAFA3 methods. It is clear that some methods are heavily based on the Naïve and BLAST baseline methods. Fig. 7Heatmap of similarity for the top 10 methods in CAFA1, CAFA2, and CAFA3. Similarity is represented by Euclidean distance of the prediction scores from each pair of methods, using the intersection set of benchmarks in the "[Top methods have improved from CAFA2 to CAFA3, but improvement was less dramatic than from CAFA1 to CAFA2](#Sec3){ref-type="sec"}" section. The higher (darker red color) the euclidean distance, the less similar the methods are. Top 10 methods from each of the CAFA challenges are displayed and ranked by their performance in *F*~max~. Cells highlighted by black borders are between a pair of methods that come from the same PI. **a**: Molecular Function; **b**: Biological Process; **c**: Cellular Component

Participating teams also provided keywords that describe their approach to function prediction with their submissions. A list of keywords was given to the participants, listed in Additional file [1](#MOESM1){ref-type="media"}. Figure [8](#Fig8){ref-type="fig"} shows the frequency of each keyword. In addition, we have weighted the frequency of the keywords with the prediction accuracy of the specific method. Machine learning and sequence alignment remain the most used approach by scientists predicting in all three ontologies. By raw count, machine learning is more popular than sequence in all three ontologies, but once adjusted by performance, their difference shrinks. In MFO, sequence alignment even overtakes machine learning as the most popular keyword after adjusting for performance. This indicates that methods that use sequence alignments are more helpful in predicting the correct function than the popularity of their use suggests. Fig. 8Keyword analysis of all CAFA3 participating methods. **a**--**c**: both relative frequency of the keywords and weighted frequencies are provided for three respective GO ontologies. The weighted frequencies accounts for the performance of the the particular model using the given keyword. If that model performs well (with high *F*~max~), then it gives more weight to the calculation of the total weighted average of that keyword. **d** shows the ratio of relative frequency between the *F*~max~-weighted and equal-weighted. Red indicates the ratio is greater than one while blue indicates the ratio is less than one. Only the top five keywords ranked by ratio are shown. The larger the ratio, the more difference there is between the *F*~max~-weighted and the equal-weighted

Evaluation via molecular screening {#Sec7}
----------------------------------

Databases with proteins annotated by biocuration, such as UniProt knowledge base and UniProt Gene Ontology Annotation (GOA) database, have been the primary source of benchmarks in the CAFA challenges. New to CAFA3, we also evaluated the extent to which methods participating in CAFA could predict the results of genetic screens in model organisms done specifically for this project. Predicting GO terms for a protein (protein-centric) and predicting which proteins are associated with a given function (term-centric) are related but different computational problems: the former is a multi-label classification problem with a structured output, while the latter is a binary classification task. Predicting the results of a genome-wide screen for a single or a small number of functions fits the term-centric formulation. To see how well all participating CAFA methods perform term-centric predictions, we mapped the results from the protein-centric CAFA3 methods onto these terms. In addition, we held a separate CAFA challenge, CAFA- *π*, whose purpose was to attract additional submissions from algorithms that specialize in term-centric tasks.

We performed screens for three functions in three species, which we then used to assess protein function prediction. In the bacterium *Pseudomonas aeruginosa* and the fungus *Candida albicans*, we performed genome-wide screens capable of uncovering genes with two functions, biofilm formation (GO:0042710) and motility (for *P. aeruginosa* only) (GO:0001539), as described in the "Methods" section. In *Drosophila melanogaster*, we performed targeted assays, guided by previous CAFA submissions, of a selected set of genes and assessed whether or not they affected long-term memory (GO:0007616).

We discuss the prediction results for each function below in detail. The performance, as assessed by the genome-wide screens, was generally lower than in the protein-centric evaluations that were curation driven. We hypothesize that it may simply be more difficult to perform term-centric prediction for broad activities such as biofilm formation and motility. For *P. aeruginosa*, an existing compendium of gene expression data was already available \[[@CR33]\]. We used the Pearson correlation over this collection of data to provide a complementary baseline to the standard BLAST approach used throughout CAFA. We found that an expression-based method outperformed the CAFA participants, suggesting that success on certain term-centric challenges will require the use of different types of data. On the other hand, the performance of the methods in predicting long-term memory in the Drosophila genome was relatively accurate.

### Biofilm formation {#Sec8}

In March 2018, there were 3019 annotations to biofilm formation (GO:0042710) and its descendent terms across all species, of which 325 used experimental evidence codes. These experimentally annotated proteins included 131 from the Candida Genome Database \[[@CR34]\] for *C. albicans* and 29 for *P. aeruginosa*, the 2 organisms that we screened.

Of the 2746 genes we screened in the *Candida albicans* colony biofilm assay, 245 were required for the formation of wrinkled colony biofilm formation (Table [1](#Tab1){ref-type="table"}). Of these, only 5 were already annotated in UniProt: *MOB*, *EED1* (*DEF1*), and *YAK1*, which encode proteins involved in hyphal growth, an important trait for biofilm formation \[[@CR35]--[@CR38]\]. Also, *NUP85*, a nuclear pore protein involved in early phase arrest of biofilm formation \[[@CR39]\] and *VPS1*, contributes to protease secretion, filamentation, and biofilm formation \[[@CR40]\]. Of the 2063 proteins that we did not find to be associated with biofilm formation, 29 were annotated with the term in the GOA database in *C. albicans*. Some of the proteins in this category highlight the need for additional information to GO term annotation. For example, Wor1 and the pheromone receptor are key for biofilm formation in strains under conditions in which the mating pheromone is produced \[[@CR41]\], but not required in the monocultures of the commonly studied a/ *α* mating type strain used here. Table 1Number of proteins in *Candida albicans* and *Pseudomonas aeruginosa* associated with the GO term "Biofilm formation" (GO:0042710) in the GOA databases versus experimental resultsGOA annotations*C. albicans*Total, 2308UnannotatedAnnotatedCAFA experimentsFalse203429True2405*P. aeruginosa*Total, 4056UnannotatedAnnotatedCAFA experimentsFalse349125True5329

We used receiver operating characteristic (ROC) curves to measure the prediction accuracy. Area under ROC curves (AUROC) was used to compare the performance. AUROC is a common accuracy measure for classification problems where it evaluates how good a model is at distinguishing between the positive and negative classes. No method in CAFA- *π* or CAFA3 (not shown) exceeded an AUC of 0.60 on this term-centric challenge (Fig. [9](#Fig9){ref-type="fig"}) for either species. Performance for the best methods slightly exceeded a BLAST-based baselines. In the past, we have found that predicting BPO terms, such as biofilm formation, resulted in poorer method performance than predicting MFO terms. Many CAFA methods use sequence alignment as their primary source of information (the "[Diversity of methods](#Sec6){ref-type="sec"}" section). For *Pseudomonas aeruginosa*, a pre-built expression compendium was available from prior work \[[@CR33]\]. Where the compendium was available, simple gene expression-based baselines were the best-performing approaches. This suggests that successful term-centric prediction of biological processes may need to rely more heavily on information that is not sequence-based and, as previously reported, may require methods that use broad collections of gene expression data \[[@CR42], [@CR43]\]. Fig. 9AUROC of the top five teams in CAFA- *π*. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. Four baseline models all based on BLAST were computed for *Candida*, while six baseline models were computed for *Pseudomonas*, including two based on expression profiles. All team methods are in gray while BLAST methods are in red, BLAST computational methods are in blue, and expression are in yellow, see Table [3](#Tab3){ref-type="table"} for the description of the baselines

### Motility {#Sec9}

In March 2018, there were 302,121 annotations for proteins with the GO term: cilium or flagellum-dependent cell motility (GO:0001539) and its descendent terms, which included cell motility in all eukaryotic (GO:0060285), bacterial (GO:0071973), and archaeal (GO:0097590) organisms. Of these, 187 had experimental evidence codes, and the most common organism to have annotations was *P. aeruginosa*, on which our screen was performed (Additional file [1](#MOESM1){ref-type="media"}: Table S2).

As expected, mutants defective in the flagellum or its motor were defective in motility (*fliC* and other *fli* and *flg* genes). For some of the genes that were expected, but not detected, the annotation was based on the experiments performed in a medium different from what was used in these assays. For example, PhoB regulates motility but only when phosphate concentration is low \[[@CR44]\]. Among the genes that were scored as defective in motility, some are known to have decreased motility due to over production of carbohydrate matrix material (*bifA*) \[[@CR45]\], or the absence of directional swimming due to absence of chemotaxis functions (e.g., *cheW*, *cheA*) and others likely showed this phenotype because of a medium-specific requirement such as biotin (*bioA*, *bioC*, and *bioD*) \[[@CR46]\]. Table [2](#Tab2){ref-type="table"} shows the contingency table for the number of proteins that are detected by our experiment versus GOA annotations. Table 2Number of proteins in *Pseudomonas aeruginosa* associated with function motility (GO:0001539) in the GOA databases versus experimental resultsGOA annotationsTotal, 3630UnannotatedAnnotatedCAFA experimentsFalse319512True40321

The results from this evaluation were consistent with what we observed for biofilm formation. Many of the genes annotated as being involved in biofilm formation were identified in the screen. Others that were annotated as being involved in biofilm formation did not show up in the screen because the strain background used here, strain PA14, uses the exopolysaccharide matrix carbohydrate Pel \[[@CR47]\] in contrast to the Psl carbohydrate used by another well-characterized strain, strain PAO1 \[[@CR48], [@CR49]\]. The *psl* genes were known to be dispensable for biofilm formation in the strain PA14 background, and this nuance highlights the need for more information to be taken into account when making predictions.

The CAFA- *π* methods outperformed our BLAST-based baselines but failed to outperform the expression-based baselines. Transferred methods from CAFA3 also did not outperform these baselines. It is important to note this consistency across terms, reinforcing the finding that term-centric prediction of biological processes is likely to require non-sequence information to be included.

### Long-term memory in *D. melanogaster* {#Sec10}

Prior to our experiments, there were 1901 annotations made in the long-term memory, including 283 experimental annotations. *Drosophila melanogaster* had the most annotated proteins of long-term memory with 217, while human has 7, as shown in Additional file [1](#MOESM1){ref-type="media"}: Table S3.

We performed RNAi experiments in *Drosophila melanogaster* to assess whether 29 target genes were associated with long-term memory (GO:0007616). Briefly, flies were exposed to wasps, which triggers a behavior that causes females to lay fewer eggs. The acute response is measured until 24 h post-exposure, and the long-term response is measured at 24 to 48 h post-exposure. RNAi was used to interfere with the expression of the 29 target genes in the mushroom body, a region of the fly brain associated with memory. Using this assay, we identified 3 genes involved in the perception of wasp exposure and 12 genes involved in the long-term memory. For details on the target selection and fly assay, see \[[@CR29]\]. None of the 29 genes had an existing annotation in the GOA database. Because no genome-wide screen results were available, we did not release this as part of the CAFA- *π* and instead relied only on the transfer of methods that predicted the "long-term memory\" at least once in *D. melanogaster* from CAFA3. Results from this assessment were more promising than our findings from the genome-wide screens in microbes (Fig. [10](#Fig10){ref-type="fig"}). Certain methods performed well, substantially exceeding the baselines. Fig. 10AUROC of top five teams in CAFA3. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. All team methods are in gray while BLAST methods are in red and BLAST computational methods are in blue, see Table [3](#Tab3){ref-type="table"} for the description of the baselines Table 3Baseline methods in term-centric evaluation of protein function predictionModel numberTraining dataScore assignmentExpression1Gene expression compendium for *P. aeruginosa PAO1*Highest correlation score out of all pairwise correlations2Top 10 average correlation scoreBLAST1All experimental annotation in UniProt-GOA. Sequences from Swiss-ProtHighest sequence identity out of all pairwise BLASTp hits2All experimental annotation in UniProt-GOA. Sequences from Swiss-Prot and TrEMBLblastcomp1All experimental and computational annotations in UniProt-GOA. Sequences from Swiss-Prot2All experimental and computational annotations in UniProt-GOA. Sequences from Swiss-Prot and TrEMBL

Participation growth {#Sec11}
--------------------

The CAFA challenge has seen growth in participation, as shown in Fig. [11](#Fig11){ref-type="fig"}. To cope with the increasingly large data size, CAFA3 utilized the Synapse \[[@CR50]\] online platform for submission. Synapse allowed for easier access for participants, as well as easier data collection for the organizers. The results were also released to the individual teams via this online platform. During the submission process, the online platform also allows for customized format checkers to ensure the quality of the submission. Fig. 11CAFA participation has been growing. Each principal investigator is allowed to head multiple teams, but each member can only belong to one team. Each team can submit up to three models

Methods {#Sec12}
=======

Benchmark collection {#Sec13}
--------------------

In CAFA3, we adopted the same benchmark generation methods as CAFA1 and CAFA2, with a similar timeline (Fig. [12](#Fig12){ref-type="fig"}). The crux of a time-delayed challenge is the annotation growth period between time *t*~0~ and *t*~1~. All target proteins that have gained experimental annotation during this period are taken as benchmarks in all three ontologies. "No knowledge" (NK, no prior experimental annotations) and "Limited knowledge" (LK, partial prior experimental annotations) benchmarks were also distinguished based on whether the newly gained experimental annotation is in an ontology that already have experimental annotations or not. Evaluation results in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} are made using the No knowledge benchmarks. Evaluation results on the Limited knowledge benchmarks are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S3. For more information regarding NK and LK designations, please refer to the Additional file [1](#MOESM1){ref-type="media"} and the CAFA2 paper \[[@CR26]\]. Fig. 12CAFA3 timeline

After collecting these benchmarks, we performed two major deletions from the benchmark data. Upon inspecting the taxonomic distribution of the benchmarks, we noticed a large number of new experimental annotations from *Candida albicans*. After consulting with UniProt-GOA, we determined these annotations have already existed in the Candida Genome Database long before 2018 but were only recently migrated to GOA. Since these annotations were already in the public domain before the CAFA3 submission deadline, we have deleted any annotation from *Candida albicans* with an assigned date prior to our CAFA3 submission deadline. Another major change is the deletion of any proteins with only a protein-binding (GO:0005515) annotation. Protein binding is a highly generalized function description, does not provide more specific information about the actual function of a protein, and in many cases may indicate a non-functional, non-specific binding. If it is the only annotation that a protein has gained, then it is hardly an advance in our understanding of that protein; therefore, we deleted these annotations from our benchmark set. Annotations with a depth of 3 make up almost half of all annotations in MFO before the removal (Additional file [1](#MOESM1){ref-type="media"}: Figure S15B). After the removal, the most frequent annotations became of depth 5 (Additional file [1](#MOESM1){ref-type="media"}: Figure S15A). In BPO, the most frequent annotations are of depth 5 or more, indicating a healthy increase of specific GO terms being added to our annotation database. In CCO, however, most new annotations in our benchmark set are of depths 3, 4, and 5 (Additional file [1](#MOESM1){ref-type="media"}: Figure S15). This difference could partially explain why the same computational methods perform very differently in different ontologies and benchmark sets. We have also calculated the total information content per protein for the benchmark sets shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S16. Taxonomic distributions of the proteins in our final benchmark set are shown in Fig. [6](#Fig6){ref-type="fig"}.

Additional analyses were performed to assess the characteristics of the benchmark set, including the overall information content of the terms being annotated.

Protein-centric evaluation {#Sec14}
--------------------------

Two main evaluation metrics were used in CAFA3, the *F*~max~ and the *S*~min~. The *F*~max~ based on the precision-recall curve (Fig. [3](#Fig3){ref-type="fig"}), while the *S*~min~ is based on the remaining uncertainty/missing information (RU-MI) curve as described in \[[@CR51]\] (Fig. [4](#Fig4){ref-type="fig"}), where *S* stands for semantic distance. The shortest semantic distance across all thresholds is used as the *S*~min~ metric. The RU-MI curve takes into account the information content of each GO term in addition to counting the number of true positives, false positives, etc., see Additional file [1](#MOESM1){ref-type="media"} for the precise definition of *F*~max~ and *S*~min~. The information theory-based evaluation metrics counter the high-throughput low-information annotations such as protein binding, but down-weighing these terms according to their information content, as the ability to predict such non-specific functions are not as desirable and useful and the ability to predict more specific functions.

The two assessment modes from CAFA2 were also used in CAFA3. In the partial mode, predictions were evaluated only on those benchmarks for which a model made at least one prediction. The full evaluation mode evaluates all benchmark proteins, and methods were penalized for not making predictions. Evaluation results in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} are made using the full evaluation mode. Evaluation results using the partial mode are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S2.

Two baseline models were also computed for these evaluations. The Naïve method assigns the term frequency as the prediction score for any protein, regardless of any protein-specific properties. BLAST was based on the results using the Basic Local Alignment Search Tool (BLAST) software against the training database \[[@CR52]\]. A term will be predicted as the highest local alignment sequence identity among all BLAST hits annotated from the training database. Both of these methods were trained on the experimentally annotated proteins and their sequences in Swiss-Prot \[[@CR53]\] at time *t*~0~.

Microbe screens {#Sec15}
---------------

To assess the matrix production, we used mutants from the PA14 NR collection \[[@CR54]\]. Mutants were transferred from the − 80 ^∘^C freezer stock using a sterile 48-pin multiprong device into 200 µl LB in a 96-well plate. The cultures were incubated overnight at 37 ^∘^C, and their OD600 was measured to assess growth. Mutants were then transferred to tryptone agar with 15 g of tryptone and 15 g of agar in 1L amended with Congo red (Aldrich, 860956) and Coomassie brilliant blue (J.T. Baker Chemical Co., F789-3). Plates were incubated at 37 ^∘^C overnight followed by 4-day incubation at room temperature to allow the wrinkly phenotype to develop. Colonies were imaged and scored on day 5. To assess motility, mutants were revived from freezer stocks as described above. After overnight growth, a sterile 48-pin multiprong transfer device with a pin diameter of 1.58 mm was used to stamp the mutants from the overnight plates into the center of swim agar made with M63 medium with 0.2% glucose and casamino acids and 0.3% agar). Care was taken to avoid touching the bottom of the plate. Swim plates were incubated at room temperature (19--22 ^∘^C) for approximately 17 h before imaging and scoring. Experimental procedures in *P. aeruginosa* to determine proteins that are associated with the two functions in CAFA- *π* are shown in Fig. [13](#Fig13){ref-type="fig"}. Fig. 13Experimental procedure of determining genes associated with the functions biofilm formation (**a**) and motility (**b**) in *P. aeruginosa*

Biofilm formation in *Candida albicans* was assessed in single gene mutants from the Noble \[[@CR55]\] and GRACE \[[@CR56]\] collections. In the Noble Collection, mutants of *C. albicans* have had both copies of the candidate gene deleted. Most of the mutants were created in biological duplicate. From this collection, 1274 strains corresponding to 653 unique genes were screened. The GRACE Collection provided mutants with one copy of each gene deleted and the other copy placed under the control of a doxycycline-repressible promoter. To assay these strains, we used a medium supplemented with 100 µg/ml doxycycline strains, when rendered them functional null mutants. We screened 2348 mutants from the GRACE Collection, 255 of which overlapped with mutants in the Noble Collection, for 2746 total unique mutants screened in total. To assess the defects in biofilm formation or biofilm-related traits, we performed 2 assays: (1) colony morphology on agar medium and (2) biofilm formation on a plastic surface (Fig. [14](#Fig14){ref-type="fig"}). For both of these assays, we used Spider medium, which was designed to induce hyphal growth in *C. albicans* \[[@CR57]\] and which promotes biofilm formation \[[@CR39]\]. Strains were first replicated from frozen 96-well plates to YPD agar plates. Strains were then replicated from YPD agar to YPD broth and grown overnight at 30 ^∘^C. From YPD broth, strains were introduced onto Spider agar plates and into 96-well plates of Spider broth. When strains from the GRACE Collection were assayed, 100 µg/ml doxycycline was included in the agar and broth, and aluminum foil was used to protect the media from light. Spider agar plates inoculated with *C. albicans* mutants were incubated at 37 ^∘^C for 2 days before colony morphologies were scored. Strains in Spider broth were shaken at 225 rpm at 37 ^∘^C for 3 days and then assayed for biofilm formation at the air-liquid interface as follows. First, broth was removed by slowly tilting the plates and pulling the liquid away by running a gloved hand over the surface. Biofilms were stained by adding 100 µl of 0.1 percent crystal violet dye in water to each well of the plate. After 15 min, plates were gently washed in three baths of water to remove dye without disturbing biofilms. To score biofilm formation for agar plates, colonies were scored by eye as either smooth, intermediate, or wrinkled. A wild-type colony would score wrinkled, and mutants with intermediate or smooth appearance were considered defective in colony biofilm formation. For biofilm formation on a plastic surface, the presence of a ring of cell material in the well indicated normal biofilm formation, while low or no ring formation mutants were considered defective. Genes whose mutations resulted defects in both or either assay were considered true for biofilm function. A complete list of the mutants identified in the screens is available in Additional file [1](#MOESM1){ref-type="media"}: Table S1. Fig. 14**a**: different phenotypes in response to doxycycline treatment: low growth, smooth, no growth and intermediate. **b**: adherence phenotypes. See text for details

A protein is considered true in the biofilm function, if its mutant phenotype is smooth or intermediate under doxycycline.

Term-centric evaluation {#Sec16}
-----------------------

The evaluations of the CAFA- *π* methods were based on the experimental results in the "[Microbe screens](#Sec15){ref-type="sec"}" section. We adopted *F*~max~ based on both precision-recall curves and area under ROC curves. There are a total of six baseline methods, as described in Table [3](#Tab3){ref-type="table"}.

Discussion {#Sec17}
==========

Since 2010, the CAFA community has been the home to a growing group of scientists across the globe sharing the goal of improving computational function prediction. CAFA has been advancing this goal in three ways. First, through independent evaluation of computational methods against the set of benchmark proteins, thus providing a direct comparison of the methods' reliability and performance at a given time point. Second, the challenge assesses the quality of the current state of the annotations, whether they are made computationally or not, and is set up to reliably track it over time. Finally, as described in this work, CAFA has started to drive the creation of new experimental annotations by facilitating synergies between different groups of researchers interested in function of biological macromolecules. These annotations not only represent new biological discoveries, but simultaneously serve to provide benchmark data for rigorous method evaluation.

CAFA3 and CAFA- *π* feature the latest advances in the CAFA series to create advanced and accurate methods for protein function prediction. We use the repeated nature of the CAFA project to identify certain trends via historical assessments. The analysis revealed that the performance of CAFA methods improved dramatically between CAFA1 and CAFA2. However, the protein-centric results for CAFA3 are mixed when compared to historical methods. Though the best-performing CAFA3 method outperformed the top CAFA2 methods (Fig. [1](#Fig1){ref-type="fig"}), this was not consistently true for other rankings. Among all 3 CAFA challenges, CAFA2 and CAFA3 methods inhabit the top 12 places in MFO and BPO. Between CAFA2 and CAFA3, the performance increase is more subtle. Based on the annotations of methods (Additional file [1](#MOESM1){ref-type="media"}), many of the top-ranking methods are improved versions of the methods that have been evaluated in CAFA2. Interestingly, the top-performing CAFA3 method, which consistently outperformed the methods from all past CAFAs in the major categories (GOLabeler \[[@CR23]\]), utilized 5 component classifiers trained from different features; those included GO term frequency, sequence alignment, amino acid trigram, domains, motifs, and biophysical properties. It performs best in the Molecular Function Ontology, where sequence features perform best. Another method which did not participate in CAFA3 yet seems to perform well under CAFA parameters is NetGO \[[@CR58]\], which utilizes the information from STRING, a network association database \[[@CR59]\] in addition to sequence information. Taken together, the strong predictive performance of mRNA co-expression data (Figs. [9](#Fig9){ref-type="fig"} and [15](#Fig15){ref-type="fig"}) leads us to hypothesize that including more varied sources of data can lead to additional large improvements in protein function prediction. We are looking forward to testing this hypothesis in future CAFA challenges. It should be noted that CAFA uses both *F*~max~ and *S*~min~. *F*~max~'s strength lies in its interpretability, as it is simply the maximum *F*~1~ given for each model. At the same time, precision/recall-based assessment does not capture the hierarchical nature of ontologies or the differences in information content between different GO terms. For that reason, we also use the *S*~min~ score which incorporates information content, but is somewhat less interpretable than *F*~max~ and less robust to the problems of incomplete annotation \[[@CR60], [@CR61]\]. Additionally, since the information content of a GO term is derived from its frequency in the corpus \[[@CR62]\], it is somewhat malleable depending on the corpus from which it is derived. We therefore use both measures for scoring, to achieve a more comprehensive picture of the models' performance. Fig. 15AUROC of top 5 teams in CAFA- *π*. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. All team methods are in gray while BLAST methods are in red, BLAST computational methods are in blue and expression are in yellow. See Table [3](#Tab3){ref-type="table"} for description of the baselines

For this iteration of CAFA, we performed genome-wide screens of phenotypes in *P. aeruginosa* and *C. albicans* as well as a targeted screen in *D. melanogaster*. This not only allowed us to assess the accuracy with which methods predict genes associated with select biological processes, but also to use CAFA as an additional driver for new biological discovery. Note that high-throughput screening for a single phenotype should be interpreted with caution as the phenotypic effect may be the result of pleiotropy, and the phenotype in question may be expressed as part of a set of other phenotypes. The results of genome-wide screenings typically lack context for the observed phenotypic effects, and each genotype-phenotype association should be examined individually to ascertain how immediate is the phenotypic effect from the seeming genotypic cause.

In sum, our experimental work identified more than a thousand new functional annotations in three highly divergent species. Though all screens have certain limitations, the genome-wide screens also bypass questions of biases in curation. This evaluation provides key insights: CAFA3 methods did not generalize well to selected terms. Because of that, we ran a second effort, CAFA- *π*, in which participants focused solely on predicting the results of these targeted assays. This targeted effort led to improved performance, suggesting that when the goal is to identify genes associated with a specific phenotype, tuning methods may be required.

For CAFA evaluations, we have included both Naïve and sequence-based (BLAST) baseline methods. For the evaluation of *P. aeruginosa* screen results, we were also able to include a gene expression baseline from a previously published compendium \[[@CR33]\]. Intriguingly, the expression-based predictions outperformed the existing methods for this task. In future CAFA efforts, we will include this type of baseline expression-based method across evaluations to continue to assess the extent to which this data modality informs gene function prediction. The results from the CAFA3 effort suggest that gene expression may be particularly important for successfully predicting term-centric biological process annotations.

The primary takeaways from CAFA3 are as follows: (1) genome-wide screens complement annotation-based efforts to provide a richer picture of protein function prediction; (2) the best-performing method was a new method, instead of a light retooling of an existing approach; (3) gene expression, and more broadly, systems data may provide key information to unlocking biological process predictions, and (4) performance of the best methods has continued to improve. The results of the screens released as part of CAFA3 can lead to a re-examination of approaches which we hope will lead to improved performance in CAFA4.
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